Short Interest in BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Increases By 10.3%

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the recipient of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 3,200 shares, an increase of 10.3% from the December 31st total of 2,900 shares. Based on an average daily volume of 154,200 shares, the short-interest ratio is presently 0.0 days.

BriaCell Therapeutics Stock Performance

NASDAQ BCTXW traded down $0.01 during trading hours on Monday, reaching $0.16. The company’s stock had a trading volume of 353,791 shares, compared to its average volume of 117,700. BriaCell Therapeutics has a 1-year low of $0.11 and a 1-year high of $1.89. The company’s 50-day moving average is $0.28 and its two-hundred day moving average is $0.27.

BriaCell Therapeutics Company Profile

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.